Abstract
BackgroundBiological agents are used to treat chronic arthritis according to the standard doses from phase III clinical trials. However, in some patients, a good response to treatment may allow the...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
